postpartum hemorrhage - Nursing Case Study

Pathophysiology

• Primary mechanism: Uterine atony - This is the failure of the uterus to contract effectively after delivery, which is crucial for compressing the blood vessels and preventing excessive bleeding. It remains the leading cause of postpartum hemorrhage, often triggered by prolonged labor, over-distended uterus, or use of certain medications.

• Secondary mechanism: Retained placental tissue - Fragments of the placenta or membranes remaining in the uterus can impede effective uterine contraction, causing continued bleeding. This may occur due to incomplete placental separation or abnormal placental attachment.

• Key complication: Coagulopathy - Excessive blood loss can lead to depletion of clotting factors, resulting in a bleeding disorder that exacerbates hemorrhage. This can quickly escalate, requiring prompt intervention to restore hemostasis and prevent severe maternal morbidity.

Patient Profile

Demographics:

32-year-old female, teacher

History:

• Key past medical history: Previous cesarean section

• Current medications: Prenatal vitamins, iron supplements

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Excessive vaginal bleeding postpartum

• Key symptoms: Dizziness, fatigue, lower abdominal pain

• Vital signs: Blood pressure 90/60 mmHg, heart rate 110 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F

Section 1

As the medical team continues to manage the postpartum hemorrhage, the patient's condition begins to show signs of further complications. Despite initial interventions aimed at addressing uterine atony and removing retained placental fragments, the patient's bleeding has not significantly abated. New laboratory results reveal a concerning drop in hemoglobin levels to 7 g/dL, indicating significant blood loss. Additionally, her platelet count has decreased to 90,000/mm³, suggestive of a developing coagulopathy. These findings necessitate immediate transfusion of packed red blood cells and fresh frozen plasma to stabilize her hematologic status and address the emerging coagulopathy.

Clinically, her vital signs remain unstable, with her blood pressure dropping further to 85/55 mmHg and heart rate increasing to 120 bpm, indicating worsening hemodynamic instability. The patient also reports increased dizziness and confusion, suggesting inadequate cerebral perfusion due to ongoing hypovolemia. Physical examination reveals a boggy uterus, confirming persistent atony, and a bedside ultrasound confirms small retained placental fragments that were not captured earlier. The priority now is to enhance uterine tone with additional uterotonic agents and consider surgical intervention for manual removal of any remaining placental tissue if pharmacologic measures fail.

The evolving situation underscores the need for vigilant monitoring and reevaluation of the treatment strategy. As the team prepares for potential surgical management, they must also anticipate and prepare for the possible need for further blood product support and consider consultation with hematology for coagulopathy management. The next steps will involve a careful balance of aggressive hemostatic intervention while supporting the patient's overall physiological status to prevent further deterioration.

Section 2

As the medical team implements the transfusion of packed red blood cells and fresh frozen plasma, there is an initial partial stabilization of the patient’s hematologic status. Her hemoglobin improves slightly to 8.2 g/dL, and her platelet count rises modestly to 105,000/mm³. However, despite these interventions, the patient’s hemodynamic instability persists. Her blood pressure remains alarmingly low at 88/56 mmHg, with a heart rate of 118 bpm. These vital signs, alongside her continued reports of dizziness and confusion, suggest ongoing hypovolemic shock and inadequate tissue perfusion, necessitating further aggressive intervention.

The team decides to administer additional uterotonic agents, including methylergonovine and carboprost, to attempt to control the persistent uterine atony. Simultaneously, preparations for an urgent dilation and curettage (D&C) are underway to address the retained placental fragments identified on ultrasound. As the patient is prepped for this potential surgical intervention, the team remains vigilant for signs of disseminated intravascular coagulation (DIC) given her earlier coagulopathy indicators. Coagulation studies are repeated, revealing a slightly prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT), further emphasizing the need for comprehensive management of her coagulation status.

Throughout these developments, the multidisciplinary team coordinates closely, ensuring that all necessary resources are available for both the surgical procedure and any emergent scenarios that may arise. The anesthesiology team is prepared to provide support during the D&C, and a hematologist is consulted to guide any further management of her coagulopathy. The patient's family is kept informed of her status and the ongoing efforts to stabilize her condition, highlighting the importance of clear communication during this critical phase. With the understanding that the next steps are crucial for the patient's recovery, the team remains focused on achieving hemostasis while maintaining close monitoring of her vital signs and laboratory parameters.

Section 3

As the medical team proceeds with the dilation and curettage (D&C), the patient's condition continues to be closely monitored. During the procedure, the obstetricians successfully remove the retained placental fragments, which are believed to be contributing significantly to the uterine atony. Post-procedure, there is a slight improvement in the patient's uterine tone, and her bleeding begins to decrease. However, despite these positive signs, the patient's hemodynamic status remains precarious. Her blood pressure continues to hover around 90/58 mmHg, and her heart rate remains elevated at 115 bpm. Laboratory tests reveal a further drop in hemoglobin to 7.6 g/dL, indicating ongoing blood loss or insufficient response to transfusion efforts.

In response to these findings, the team decides to increase the rate of intravenous fluid resuscitation and administer an additional unit of packed red blood cells. They also consider the potential need for further surgical intervention, such as uterine artery embolization, if the bleeding does not cease. Concurrently, the coagulation profile is reassessed, showing a further elevation in D-dimer levels and a decrease in fibrinogen, raising concerns about the development of disseminated intravascular coagulation (DIC). The hematologist recommends the administration of cryoprecipitate to address the low fibrinogen levels and advises continuous monitoring of the patient’s coagulation status.

As the team implements these additional interventions, they remain vigilant for any signs of new complications. The patient's ongoing confusion and dizziness suggest that cerebral perfusion may still be compromised, necessitating careful neurological assessment. The critical care specialist emphasizes the importance of maintaining adequate oxygenation and optimizing hemodynamic parameters to support vital organ function. The patient’s family is updated on her condition, and the team discusses potential next steps, including the need for intensive care unit monitoring. The focus remains on achieving stability and preventing further deterioration as the patient navigates this challenging recovery phase.

Section 4

As the medical team continues to monitor the patient closely, there is a noticeable change in her status. Despite the interventions, her vital signs remain concerning. Her blood pressure drops further to 85/52 mmHg, and her heart rate increases to 125 bpm, indicating a potential progression towards hypovolemic shock. The patient's skin appears cool and clammy, and her capillary refill time is delayed at over 3 seconds, suggesting inadequate peripheral perfusion. Neurologically, she becomes increasingly lethargic, with a Glasgow Coma Scale score dropping to 13, as she struggles to respond appropriately to questions and maintain alertness.

In light of these developments, the team rapidly reassesses her hemodynamic management. They opt to initiate vasopressor support with norepinephrine to stabilize her blood pressure while continuing aggressive fluid resuscitation. Additionally, another unit of packed red blood cells is cross-matched and prepared for transfusion. As concerns about potential organ dysfunction grow, a point-of-care ultrasound is performed, revealing decreased cardiac contractility and potential early signs of acute kidney injury, evidenced by oliguria and rising serum creatinine levels.

Recognizing the gravity of the situation, the team decides to transfer the patient to the intensive care unit for closer monitoring and advanced hemodynamic support. The critical care team prepares for possible escalation in treatment, including continuous renal replacement therapy if renal function continues to decline. Throughout these developments, the importance of maintaining open lines of communication with the patient's family is emphasized, ensuring they are informed and involved in decision-making as the patient battles through this complex and precarious phase of recovery.

Section 5

As the patient is transferred to the intensive care unit, the critical care team conducts a thorough initial assessment to establish a baseline for her current condition. Vital signs are closely monitored, revealing a slight improvement in blood pressure to 92/58 mmHg with the initiation of norepinephrine, but the heart rate remains elevated at 122 bpm. Her respiratory rate increases to 28 breaths per minute, indicating potential respiratory compromise. Blood gas analysis shows a metabolic acidosis with a pH of 7.31, a bicarbonate level of 18 mEq/L, and a lactic acid level of 4.5 mmol/L, reflecting ongoing tissue hypoperfusion and hypoxia. The patient’s urine output has decreased further to less than 20 mL/hour, confirming the progression of acute kidney injury.

Laboratory results return, providing further insight into her deteriorating condition. Hemoglobin levels have dropped to 7.2 g/dL, necessitating the transfusion of additional packed red blood cells to address the significant anemia. Coagulation studies reveal a slightly prolonged prothrombin time and activated partial thromboplastin time, raising concerns about possible disseminated intravascular coagulation (DIC) as a complication of the postpartum hemorrhage. Serum electrolytes indicate hyperkalemia, with potassium levels at 5.8 mEq/L, which requires prompt management to prevent cardiac arrhythmias.

The critical care team focuses on a multifaceted approach to her management, which includes adjusting fluid resuscitation to optimize her hemodynamic status while starting continuous renal replacement therapy to address the acute kidney injury and electrolyte imbalances. As the medical team continues to support the patient's physiological stability, they remain vigilant for signs of further complications, such as respiratory failure or worsening coagulopathy. The patient’s family is kept informed of these developments, emphasizing the need for ongoing critical interventions and the potential for further treatment adjustments as the patient’s condition evolves.